Biocompatible soft hydrogel lens as topical implants for diabetic retinopathy
Abstract
Fashioned contact lenses can be converted into novel drug delivery vehicles. Ocular disease like diabetic retinopathy is a major microvascular complication where its early diagnosis and treatment is still a mystery to clinicians. Delivery of pharmaceuticals to the posterior part of eye is quite difficult, with exemption from the injectable formulations. Drug loaded hydrogel like contact lens implants can be utilized in place of commercial contact lens. Such hydrogel lens implants are developed with precise manner in which they are to be inserted as implants in the mice models. The present work is the preliminary outcome of our ongoing research work where the polymerized lens implant can be used as payload carrier for retinopathy. The aim is to propose such appropriate implants suitable for in vivo mice models.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Laser-activated drug implant for controlled release to the posterior segment of the eye
- 3D human retinal organoid model for the study of early diabetic retinopathy
Luísa de Lemos, Pedro Antas, … Sandra Tenreiro·bioRxiv·Sep 4, 2023
- Efficient Hydrophilic Small Molecule Delivery To Retinal Cell Lines Using Solid Lipid Nanoparticle Containing Gel Core
Li Huang, Erico Himawan, … Valeria Marigo·PharmaceuticsPeer-reviewed·Dec 28, 2021
- Injectable polymer-nanoparticle hydrogel for the sustained intravitreal delivery of bimatoprost
E. L. Meany, R. Andaya, … E. Appel·bioRxiv·Sep 8, 2022
- Filomicelle-Embedded Composite Hydrogels for Localized Gelation within the Anterior Chamber of the Eye
Hyeohn Kim, Sofia Lara Ochoa, … Evan Alexander Scott·SmallPeer-reviewed·Dec 17, 2025
- A new high-resolution three-dimensional retinal implant: System design and preliminary human results
L. Yanovitch, D. Raz-Prag, Y. Hanein·bioRxiv·Sep 14, 2022